|
Volumn 22, Issue 4 SUPPL. 8, 1995, Pages 16-22
|
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: A European Cancer Center Trial
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKALINE PHOSPHATASE;
AMINOTRANSFERASE;
ANTHRACYCLINE DERIVATIVE;
BILIRUBIN;
CIMETIDINE;
CLEMASTINE;
DEXAMETHASONE;
DOXORUBICIN;
EPIRUBICIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
LIVER ENZYME;
PACLITAXEL;
ADULT;
AGED;
AREA UNDER THE CURVE;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER CENTER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG MEGADOSE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER METASTASIS;
MULTICENTER STUDY;
MUSCULOSKELETAL DISEASE;
NEUROPATHY;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
BREAST NEOPLASMS;
COHORT STUDIES;
DISEASE PROGRESSION;
DRUG RESISTANCE;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUKOPENIA;
LIVER NEOPLASMS;
MIDDLE AGED;
NETHERLANDS;
NEUTROPENIA;
PACLITAXEL;
PERIPHERAL NERVOUS SYSTEM DISEASES;
REMISSION INDUCTION;
SAFETY;
THROMBOCYTOPENIA;
|
EID: 0029115526
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (46)
|
References (0)
|